Howard A. Anderson1, 6, Caroline A. Maylock2, 6, Joy A. Williams3, Cloud P. Paweletz4, Hongjun Shu5
& Emily Shacter11
Laboratory of Biochemistry, Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.
2
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD 20815, USA.
3
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
4
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
5
Department of Pharmacology, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA.
6
These authors contributed equally to this work.
Correspondence should be addressed to Emily Shacter shacter@cber.fda.gov
